Dr. Nora Rose Sudarsan, DO

Dr. Sudarsan practices at Medstar Medical Group II in Arlington, Virginia.

Dr. Sudarsan's NPI, 1275809246, was assigned on March 23, 2012. Dr. Sudarsan graduated from Touro Un Col of Osteopathic Medicine, New York in 2012. Dr. Sudarsan holds Maryland license H0085147.

Dr. Sudarsan's primary practice is Medstar Medical Group II, at 2000 15th N St, Arlington, VA 22201 in Arlington County. The practice phone is (443) 444-5606.

Dr. Sudarsan's primary practice is Medstar Medical Group II in Arlington, Virginia. Dr. Sudarsan is also affiliated with WellSpan York Hospital. The medical group on file is WellSpan Urology - Lebanon. Dmand AI also links Dr. Sudarsan to 3 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sudarsan practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Sudarsan's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Sudarsan is licensed in Maryland.

CMS data shows 1,785 Medicare services from Dr. Sudarsan across 9 procedure codes in 2024, for 425 Medicare patients. Medicare paid $183,177 for them.

CMS counts 425 Medicare patients who saw Dr. Sudarsan in 2024. The largest group is 65 to 74, with 162 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sudarsan's median patient age at 71, with 65% women.

In 2024, Dr. Sudarsan wrote 741 Medicare Part D claims for 136 patients. 72% of them were for generic drugs. CMS names the drug for 494 of them, across 21 drugs with 11 or more claims each, at $1,358,990 in total drug cost. In 2023, CMS named 268 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Sudarsan for performance year 2024, reported as part of a group. Dr. Sudarsan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sudarsan as offering telehealth.

Dmand AI links 2 papers to Dr. Sudarsan in 2015. Dr. Sudarsan's most frequent co-authors are Carol Aghajanian, MD, George J. Bosl, MD and Darren Richard Feldman, MD.

CMS Open Payments shows 262 general payments to Dr. Sudarsan from 52 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 71% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,757.

Dr. Sudarsan graduated from Touro Un Col of Osteopathic Medicine, New York in 2012.